DSP-7888
Total Payments
$2.2M
Transactions
321
Doctors
11
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $2.1M | 314 | 6 |
| 2017 | $16,353 | 7 | 7 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.2M | 321 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DSP-7888 | Sumitomo Dainippon Pharma Co., Ltd. | $2.1M | 6 |
| A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies | Sumitomo Dainippon Pharma Co., Ltd. | $16,353 | 7 |
Top Doctors Receiving Payments for DSP-7888
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Lexington, KY | $2.1M | 307 |
| , M.D | Specialist | Canton, OH | $6,102 | 1 |
| , M.D | Medical Oncology | Houston, TX | $5,100 | 2 |
| , MD | Neurological Surgery | Mill Valley, CA | $2,700 | 1 |
| , MD | Hematology & Oncology | Cleveland, OH | $2,700 | 1 |
| , MD | Neurological Surgery | Reisterstown, MD | $2,700 | 1 |
| , M.D | Hematology & Oncology | Chapel Hill, NC | $2,400 | 3 |
| , M.D | Pediatric Hematology-Oncology | Evanston, IL | $2,400 | 1 |
| Jason Sheehan | Neurological Surgery | Charlottesville, VA | $2,000 | 1 |
| , MD | Neurology | Los Angeles, CA | $1,800 | 1 |
| Richard Larson | Hematology & Oncology | Chicago, IL | $1,800 | 1 |
| David Reardon | Hematology & Oncology | Boston, MA | $650.74 | 1 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $2.2M
- Total Doctors 11
- Transactions 321
About DSP-7888
DSP-7888 is a drug associated with $2.2M in payments to 11 healthcare providers, recorded across 321 transactions in the CMS Open Payments database. The primary manufacturer is Sumitomo Dainippon Pharma Co., Ltd..
Payment data is available from 2017 to 2018. In 2018, $2.1M was paid across 314 transactions to 6 doctors.
The most common payment nature for DSP-7888 is "Unspecified" ($2.2M, 100.0% of total).
DSP-7888 is associated with 2 research studies, including "DSP-7888" ($2.1M).